How KeyBanc Capital Mkts Currently Rates Halyard Health (NYSE:HYH)
KeyBanc Capital Mkts issued Sector Weight rating on Halyard Health (NYSE:HYH). The firm have commenced coverage coverage on shares of HYH in recent note revealed to investors on 18 December.
From a total of 4 analysts covering Halyard Health Inc (NYSE:HYH) stock, 0 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that NaN of the ratings are positive. The highest target price is $40 while the lowest target price is $27. The mean of all analyst targets is $36.25 with a 8.27% above today’s ($33.48) stock price. Halyard Health Inc was the topic of 6 analyst reports since July 21, 2015 according to the firm StockzIntelligence Inc. Stifel Nicolaus initiated shares on December 2 with “Buy” rating. Deutsche Bank initiated HYH stock in a recent report from September 11 with “Buy” rating.
Approximately 200,057 shares of stock traded hands. Halyard Health Inc (NYSE:HYH) has declined 21.04% since May 15, 2015 and is downtrending. It has underperformed by 17.23% the S&P500.
Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The company has a market cap of $1.54 billion. The Firm has two business divisions: Surgical and Infection Prevention and Medical Devices. It currently has negative earnings. The Company’s S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.
According to Zacks Investment Research, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia.”